SEC Form 4 · accession 0001123292-15-000755
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Belsky
Officer — SVP and CFO
Period of report
Apr 30, 2015
Accepted (ET)
May 4, 2015 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 30, 2015 | A | 5,680 | $0.00 | A | 5,680 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock, which will vest fully on January 3, 2017, provided the reporting person remains employeed by the Company.